Publications by authors named "Alexander Berchanski"

Claim this Profile
I
Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside-polyarginine conjugates.
Alexander Berchanski, Alexander Kalinkovich, Aya Ludin, Tsvee Lapidot, Aviva Lapidot

FEBS J· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteopedia: a status report on the collaborative, 3D web-encyclopedia of proteins and other biomolecules.
Jaime Prilusky, Eran Hodis, David Canner, Wayne A Decatur, Karl Oberholser, Alexander Berchanski

J Struct Biol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites.
Alexander Berchanski, Aviva Lapidot

J Mol Model· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.
Aviva Lapidot, Alexander Berchanski, Gadi Borkow

FEBS J· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates.
Alexander Berchanski, Aviva Lapidot

Bioconjug Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
Aviva Lapidot, Amnon Peled, Alexander Berchanski, Boaz Pal, Orit Kollet

Biochim Biophys Acta· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
Ravi Hegde, Gadi Borkow, Alexander Berchanski, Aviva Lapidot

FEBS J· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure.
Alexander Berchanski, Aviva Lapidot

Biochim Biophys Acta· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling oligomers with Cn or Dn symmetry: application to CAPRI target 10.
Alexander Berchanski, Dadi Segal, Miriam Eisenstein

Proteins· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrophobic complementarity in protein-protein docking.
Alexander Berchanski, Boaz Shapira, Miriam Eisenstein

Proteins· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of molecular assemblies via docking: modeling of tetramers with D2 symmetry.
Alexander Berchanski, Miriam Eisenstein

Proteins· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of the unknown: inspiring experience with the CAPRI experiment.
Efrat Ben-Zeev, Alexander Berchanski, Alexander Heifetz, Boaz Shapira, Miriam Eisenstein

Proteins· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis